ATLASPharming Group N.V. ADR (PHAR) earnings date: expected February 2–8
Pharming Group N.V. ADR (PHAR) has not announced its next earnings date yet. Based on its last 3 reports, ATLAS expects it around February 2–8. That is an estimate, not a confirmed date.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on PHAR
| Last price | $12.23 (+0.8%) |
|---|---|
| Normal 1-day range (±1σ) | ±3.5% |
| Earnings beat history | Beat the EPS estimate in 2 of the last 5 reports |
These figures come from the same calibrated model and valuation as the Pharming Group N.V. ADR stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Expected around February 2–8 (estimate). One email the day before, with ATLAS’s read on Pharming Group N.V. ADR. You can switch it off at any time.
Alert me before PHAR reportsFree to start. Creating an account takes under a minute.
PHAR earnings at a glance
| Next report | Not announced · expected around February 2–8 (ATLAS estimate) |
|---|---|
| Last report | Oct 27, 2026 · Miss |
| Beat rate (last 5 reports) | 2 of 5 (40%) |
| Average EPS surprise | +125.3% |
| Average move around a report | ±3.1% (last 5) |
| Sector | Healthcare · Biotechnology |
The expected window is an ATLAS estimate: it takes the typical gap between Pharming Group N.V. ADR’s last 3 reports and adds it to the most recent one. Companies announce the real date a few weeks ahead, and ATLAS switches the page to the confirmed date as soon as it is published.
Pharming Group N.V. ADR earnings history: last 5 reports
Pharming Group N.V. ADR last reported on Oct 27, 2026: EPS of $0.30 against an estimate of $0.33 (-9.1% surprise), a miss.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Oct 27, 2026 | $0.33 | $0.30 | -9.1% | Miss | +3.0% |
| Jun 17, 2026 | $3.12 | $3.16 | +1.3% | In line | +2.9% |
| Jun 8, 2026 | $0.33 | $0.49 | +48.5% | Beat | +0.4% |
| Apr 9, 2026 | -$0.07 | -$0.08 | -14.3% | Miss | +0.7% |
| Mar 12, 2026 | $0.01 | $0.07 | +600.0% | Beat | -8.6% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for PHAR
See the fair value, the probability range and the earnings history of Pharming Group N.V. ADR on its ATLAS page.
Pharming Group N.V. ADR (PHAR) stock analysisPlans from €3.99 a month.
Pharming Group N.V. ADR earnings: frequently asked questions
When is Pharming Group N.V. ADR (PHAR) next earnings date?
Pharming Group N.V. ADR has not announced its next report. Its last 3 reports came Oct 27, 2026, Jun 17, 2026, Apr 9, 2026, so ATLAS estimates the next one around February 2–8. This is an estimate based on that pattern, not a confirmed date.
How often does PHAR beat earnings estimates?
Of its last 5 reports with a recorded result, Pharming Group N.V. ADR beat the EPS estimate 2 times; the average surprise was +125.3%. Past results do not predict the next one.
How much does PHAR move around earnings?
Over its last 5 reports the stock moved an average of 3.1% (absolute, from the close before the report day to the close after it), and finished higher 4 of 5 times.
Did Pharming Group N.V. ADR beat earnings estimates last quarter?
Pharming Group N.V. ADR last reported on Oct 27, 2026: EPS of $0.30 against an estimate of $0.33 (-9.1% surprise), a miss.
How much does PHAR usually move in a day?
On a normal trading day the ATLAS model puts PHAR’s one-day range at about ±3.5%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Educational information, not investment advice. Disclaimer